CIITA-related block of HLA class II expression, upregulation of HLA class I, and heterogeneous expression of immune checkpoints in hepatocarcinomas: implications for new therapeutic approaches
Author:
Affiliation:
1. Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy
Funder
European Community
University of Insubria
University of Insubria and Regione Lombardia
Publisher
Informa UK Limited
Subject
Oncology,Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1548243
Reference58 articles.
1. Earlier presentation and application of curative treatments in hepatocellular carcinoma
2. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial
3. The future of immune checkpoint therapy
4. Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches
5. Immune Checkpoint Inhibition in Hepatocellular Carcinoma: Basics and Ongoing Clinical Trials
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel vaccination strategies based on optimal stimulation of CD4+ T helper cells for the treatment of oral squamous cell carcinoma;Frontiers in Immunology;2024-07-05
2. Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?;Cells;2024-01-12
3. A molecular classification system for estimating radiotherapy response and anticancer immunity for individual breast cancer patients;Frontiers in Oncology;2023-10-20
4. Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities;British Journal of Cancer;2023-07-15
5. Genetic haplotypes associated with immune response to Leishmania infantum infection in dogs;Veterinary Research Communications;2023-04-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3